ProQR Therapeutics NV
F:0PQ
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
ProQR Therapeutics NV
F:0PQ
|
NL |
|
S
|
Sojitz Corp
SWB:XEB
|
JP |
|
Image Resources NL
F:I5R
|
AU |
|
B
|
Bursa Cimento Fabrikasi AS
IST:BUCIM.E
|
TR |
|
T
|
Tokyo Tatemono Co Ltd
OTC:TYTMF
|
JP |
|
American Lithium Minerals Inc
OTC:AMLM
|
US |
|
Windlas Biotech Ltd
NSE:WINDLAS
|
IN |
|
K
|
KINX Inc
KOSDAQ:093320
|
KR |
|
Shemaroo Entertainment Ltd
BSE:538685
|
IN |
|
Hoshizaki Corp
F:HS0
|
JP |
|
S
|
Sentia ASA
F:Z9P
|
NO |
|
eDreams ODIGEO SA
OTC:EDDRF
|
ES |
|
D
|
DeNA Co Ltd
OTC:DNACF
|
JP |
|
Innovative Eyewear Inc
NASDAQ:LUCY
|
US |
|
S
|
Sungwoo Co Ltd
KOSDAQ:458650
|
KR |
|
Tokai Carbon Co Ltd
TSE:5301
|
JP |
|
C
|
CrowdStrike Holdings Inc
SWB:45C
|
US |
|
Raubex Group Ltd
F:B7P
|
ZA |
|
S
|
Seosan Co Ltd
KOSDAQ:079650
|
KR |
|
Edenred SE
PAR:EDEN
|
FR |
|
W
|
Wallbridge Mining Company Ltd
XMUN:WC7
|
CA |
Bankruptcy Probability
ProQR Therapeutics NV's probability of bankruptcy is Hidden . The solvency score is Hidden .
We take all the information about a company's solvency, such as how easily it can pay interest on outstanding debt, how much cash it has, the amount of debt, and more, and use it to estimate the probability of bankruptcy.
Solvency Ratios
Solvency Ratios Comparison
ProQR Therapeutics NV Competitors
| Country | Company | Market Cap | D/E | D/A |
Interest Coverage |
Altman Z-Score |
Quick Ratio |
Current Ratio |
Cash Ratio |
||
|---|---|---|---|---|---|---|---|---|---|---|---|
| NL |
|
ProQR Therapeutics NV
NASDAQ:PRQR
|
175m USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
AbbVie Inc
NYSE:ABBV
|
506.7B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Amgen Inc
NASDAQ:AMGN
|
240.5B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Gilead Sciences, Inc
NASDAQ:GILD
|
196.9B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
|
131.1B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
|
83.5B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Moderna Inc
NASDAQ:MRNA
|
79.3B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| AU |
|
CSL Ltd
ASX:CSL
|
88.4B AUD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Natera Inc
NASDAQ:NTRA
|
58.1B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| NL |
|
argenx SE
XBRU:ARGX
|
48.8B EUR |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Revolution Medicines Inc
NASDAQ:RVMD
|
39.4B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
ProQR Therapeutics NV's probability of bankruptcy is Hidden .
The probability of bankruptcy is estimated using credit risk models that assess financial health, debt levels, interest coverage, and other solvency indicators.
As of the latest report, ProQR Therapeutics NV has total debt of 8.7m EUR. This includes both short-term (0 EUR) and long-term (8.7m EUR) debt.
You can find a full breakdown on its Balance Sheet.